{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T04:33:29Z","timestamp":1777350809215,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,3,4]],"date-time":"2027-03-04T00:00:00Z","timestamp":1804118400000},"content-version":"am","delay-in-days":672,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903468"],"award-info":[{"award-number":["81903468"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010029","name":"Taishan Scholar Foundation of Shandong Province","doi-asserted-by":"publisher","award":["tsqn202211232"],"award-info":[{"award-number":["tsqn202211232"]}],"id":[{"id":"10.13039\/501100010029","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010029","name":"Taishan Scholar Foundation of Shandong Province","doi-asserted-by":"publisher","award":["tsqn202306008"],"award-info":[{"award-number":["tsqn202306008"]}],"id":[{"id":"10.13039\/501100010029","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2019BH068"],"award-info":[{"award-number":["ZR2019BH068"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2023QH354"],"award-info":[{"award-number":["ZR2023QH354"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2024YQ072"],"award-info":[{"award-number":["ZR2024YQ072"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ejmech.2025.117441","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T11:18:50Z","timestamp":1740395930000},"page":"117441","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Design and biochemical evaluation of 2-cyclopropyl-thioureidobenzamide (CP-TBA) derivatives as potent HBV capsid assembly modulators targeting a novel binding site"],"prefix":"10.1016","volume":"289","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5734-2528","authenticated-orcid":false,"given":"Mei","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutong","family":"Dou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aixin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zechun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minghui","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqing","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunfu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuanchang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyong","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117441_bib1","author":"Hepatitis","year":"2022"},{"key":"10.1016\/j.ejmech.2025.117441_bib2","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jhep.2021.11.024","article-title":"How to achieve functional cure of HBV: Stopping NUCs, adding interferon or new drug development?","volume":"76","author":"Wong","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejmech.2025.117441_bib3","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41575-020-0332-6","article-title":"Progress towards elimination goals for viral hepatitis","volume":"17","author":"Cox","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejmech.2025.117441_bib4","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1053\/j.gastro.2018.10.048","article-title":"What is needed to eliminate hepatitis B virus and hepatitis C virus as global health threats","volume":"156","author":"Ward","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejmech.2025.117441_bib5","first-page":"134","article-title":"A current management strategy for children with chronic viral hepatitis B, based on international and national guidelines","volume":"27","author":"Nesina","year":"2023","journal-title":"J Mother Child"},{"key":"10.1016\/j.ejmech.2025.117441_bib6","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s40265-023-01843-2","article-title":"Emerging therapies for chronic hepatitis B and the potential for a functional cure","volume":"83","author":"Chang","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2025.117441_bib7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.antiviral.2017.11.015","article-title":"The diverse functions of the hepatitis B core\/capsid protein (HBc) in the viral life cycle: implications for the development of HBc-targeting antivirals","volume":"149","author":"Diab","year":"2018","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ejmech.2025.117441_bib8","doi-asserted-by":"crossref","first-page":"10262","DOI":"10.1128\/JVI.01360-08","article-title":"Small-molecule effectors of hepatitis B virus capsid assembly give insight into virus life cycle","volume":"82","author":"Bourne","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2025.117441_bib9","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/cphc.201800211","article-title":"Localizing conformational hinges by NMR: where do hepatitis B virus core proteins adapt for capsid assembly?","volume":"19","author":"Lecoq","year":"2018","journal-title":"ChemPhysChem"},{"key":"10.1016\/j.ejmech.2025.117441_bib10","doi-asserted-by":"crossref","first-page":"8536","DOI":"10.1021\/jacs.1c12439","article-title":"Transient RNA interactions leave a covalent imprint on a viral capsid protein","volume":"144","author":"Harati Taji","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.117441_bib11","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1080\/17460441.2023.2239701","article-title":"The premise of capsid assembly modulators towards eliminating HBV persistence","volume":"18","author":"Bassit","year":"2023","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.ejmech.2025.117441_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2023.108349","article-title":"Medicinal chemistry strategies in the discovery and optimization of HBV core protein allosteric modulators (2018\u20132022 update)","volume":"34","author":"Shao","year":"2023","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117441_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025096","article-title":"Antiviral activity of Bay 41-4109 on hepatitis B virus in humanized Alb-uPA\/SCID mice","volume":"6","author":"Brezillon","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2025.117441_bib14","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/jmr.801","article-title":"BAY 41-4109 has multiple effects on Hepatitis B virus capsid assembly","volume":"19","author":"Stray","year":"2006","journal-title":"J Mol Recognit"},{"key":"10.1016\/j.ejmech.2025.117441_bib15","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/cid\/ciaa961","article-title":"Antiviral activity and pharmacokinetics of the hepatitis B virus (HBV) capsid assembly modulator GLS4 in patients with chronic HBV infection","volume":"73","author":"Zhang","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2025.117441_bib16","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S2468-1253(21)00176-X","article-title":"Safety, pharmacokinetics, and antiviral activity of RO7049389, a core protein allosteric modulator, in patients with chronic hepatitis B virus infection: a multicentre, randomised, placebo-controlled, phase 1 trial","volume":"6","author":"Yuen","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.ejmech.2025.117441_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2023.105715","article-title":"A novel hepatitis B virus capsid assembly modulator QL-007 inhibits HBV replication and infection through altering capsid assembly","volume":"218","author":"Xi","year":"2023","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ejmech.2025.117441_bib18","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.antiviral.2007.06.014","article-title":"The phenylpropenamide derivative AT-130 blocks HBV replication at the level of viral RNA packaging","volume":"76","author":"Feld","year":"2007","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ejmech.2025.117441_bib19","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1053\/j.gastro.2018.12.023","article-title":"Antiviral activity, safety, and pharmacokinetics of capsid assembly modulator NVR 3-778 in patients with chronic HBV infection","volume":"156","author":"Yuen","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejmech.2025.117441_bib20","doi-asserted-by":"crossref","first-page":"13968","DOI":"10.1021\/acs.jmedchem.3c01022","article-title":"Design, synthesis, and biological evaluation of novel thioureidobenzamide (TBA) derivatives as HBV capsid assembly modulators","volume":"66","author":"Wang","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117441_bib21","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02439-19","article-title":"Antiviral properties and mechanism of action studies of the hepatitis B virus capsid assembly modulator JNJ-56136379","volume":"64","author":"Berke","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.117441_bib22","article-title":"Novel hepatitis B virus capsid assembly modulator induces potent antiviral responses in vitro and in humanized mice","volume":"64","author":"Amblard","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.117441_bib23","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12916-023-02814-w","article-title":"Safety, tolerability, pharmacokinetics, and antiviral activity of the novel core protein allosteric modulator ZM-H1505R (Canocapavir) in chronic hepatitis B patients: a randomized multiple-dose escalation trial","volume":"21","author":"Jia","year":"2023","journal-title":"BMC Med."},{"key":"10.1016\/j.ejmech.2025.117441_bib24","doi-asserted-by":"crossref","first-page":"16773","DOI":"10.1021\/acs.jmedchem.4c01568","article-title":"Rational design, synthesis, and structure-activity relationship of a novel isoquinolinone-based series of HBV capsid assembly modulators leading to the identification of clinical candidate AB-836","volume":"67","author":"Cole","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117441_bib25","article-title":"Heteroaryldihydropyrimidine (HAP) and sulfamoylbenzamide (SBA) inhibit hepatitis B virus replication by different molecular mechanisms","volume":"7","author":"Zhou","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.117441_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11051349","article-title":"Capsid assembly modulators as antiviral agents against HBV: molecular mechanisms and clinical perspectives","volume":"11","author":"Taverniti","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ejmech.2025.117441_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/v9030056","article-title":"Complete and incomplete hepatitis B virus particles: formation, function, and application","volume":"9","author":"Hu","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2025.117441_bib28","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00722-23","article-title":"Novel non-HAP class A HBV capsid assembly modulators have distinct in vitro and in vivo profiles","author":"Vanrusselt","year":"2023","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2025.117441_bib29","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/cbdd.13512","article-title":"Design, synthesis, and evaluation of novel heteroaryldihydropyrimidine derivatives as non-nucleoside hepatitis B virus inhibitors by exploring the solvent-exposed region","volume":"95","author":"Yu","year":"2020","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2025.117441_bib30","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1021\/acs.jmedchem.3c00173","article-title":"Discovery of linvencorvir (RG7907), a hepatitis B virus core protein allosteric modulator, for the treatment of chronic HBV infection","volume":"66","author":"Zhang","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117441_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113780","article-title":"Design, synthesis and evaluation of heteroaryldihydropyrimidine analogues bearing spiro ring as hepatitis B virus capsid protein inhibitors","volume":"225","author":"Ma","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117441_bib32","doi-asserted-by":"crossref","first-page":"6247","DOI":"10.1021\/acs.jmedchem.8b00654","article-title":"Synthesis and evaluation of N-phenyl-3-sulfamoyl-benzamide derivatives as capsid assembly modulators inhibiting hepatitis B virus (HBV)","volume":"61","author":"Vandyck","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117441_bib33","doi-asserted-by":"crossref","first-page":"11069","DOI":"10.1021\/jacs.2c02921","article-title":"Carbonylative N-heterocyclization via nitrogen-directed C-C bond activation of nonactivated cyclopropanes","volume":"144","author":"Calow","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.117441_bib34","doi-asserted-by":"crossref","first-page":"6987","DOI":"10.1016\/S0040-4039(02)01606-4","article-title":"Cyclopropylboronic acid: synthesis and Suzuki cross-coupling reactions","volume":"43","author":"Wallace","year":"2002","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2025.117441_bib35","doi-asserted-by":"crossref","first-page":"7604","DOI":"10.1021\/jacs.1c01770","article-title":"Meta selective C-H borylation of sterically biased and unbiased substrates directed by electrostatic interaction","volume":"143","author":"Chaturvedi","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.117441_bib36","article-title":"Synthesis of isothiocyanates by reaction of amines with phenyl chlorothionoformate via one\u2010pot or two\u2010step process","volume":"44","author":"Li","year":"2013","journal-title":"ChemInform"},{"key":"10.1016\/j.ejmech.2025.117441_bib37","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.6023\/cjoc201503026","article-title":"Improvement of the synthesis of isothiocyanates","volume":"35","author":"Li","year":"2015","journal-title":"Chin. J. Org. Chem."},{"key":"10.1016\/j.ejmech.2025.117441_bib38","doi-asserted-by":"crossref","first-page":"13968","DOI":"10.1021\/acs.jmedchem.3c01022","article-title":"Design, synthesis, and biological evaluation of novel thioureidobenzamide (TBA) derivatives as HBV capsid assembly modulators","author":"Wang","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117441_bib39","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1021\/acs.jmedchem.9b01541","article-title":"Urea derivatives in modern drug discovery and medicinal chemistry","volume":"63","author":"Ghosh","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117441_bib40","first-page":"E1264","article-title":"Complete replication of hepatitis B virus and hepatitis C virus in a newly developed hepatoma cell line","volume":"111","author":"Yang","year":"2014","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.ejmech.2025.117441_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011382","article-title":"Hepatitis B virus hijacks TSG101 to facilitate egress via multiple vesicle bodies","volume":"19","author":"Zheng","year":"2023","journal-title":"PLoS Pathog."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425002065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425002065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T14:08:38Z","timestamp":1762265318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425002065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":41,"alternative-id":["S0223523425002065"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117441","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and biochemical evaluation of 2-cyclopropyl-thioureidobenzamide (CP-TBA) derivatives as potent HBV capsid assembly modulators targeting a novel binding site","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117441","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117441"}}